SWISH-ing steroids: new standard of care to prevent everolimus-induced oral mucositis?

Affiliations

¹ Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.
² Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA. Electronic address: Bardia.Aditya@mgh.harvard.edu.

Comment

Laura Spring et al. Lancet Oncol. 2017 May.

. 2017 May;18(5):564-565.

doi: 10.1016/S1470-2045(17)30106-7. Epub 2017 Mar 15.

¹ Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.
² Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA. Electronic address: Bardia.Aditya@mgh.harvard.edu.

No abstract available

Comment on

Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial.
Rugo HS, Seneviratne L, Beck JT, Glaspy JA, Peguero JA, Pluard TJ, Dhillon N, Hwang LC, Nangia C, Mayer IA, Meiller TF, Chambers MS, Sweetman RW, Sabo JR, Litton JK. Rugo HS, et al. Lancet Oncol. 2017 May;18(5):654-662. doi: 10.1016/S1470-2045(17)30109-2. Epub 2017 Mar 15. Lancet Oncol. 2017. PMID: 28314691 Clinical Trial.